Drug Discovery Informatics Market Size Projected To Reach $6.98 Billion By 2034 With A Cagr Of 14.3%

The Drug Discovery Informatics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Drug Discovery Informatics Market Size and Projected Growth Rate?
The scale of the drug discovery informatics market has seen speedy expansion in the preceding years. Its worth is projected to escalate from $3.69 billion in 2024 to $4.09 billion in 2025, recording a compound annual growth rate (CAGR) of 11.1%. This historic period's growth has been buoyed by advancements in genomics and proteomics, escalating intricacy of drug targets, evolution in structural biology, a surge in outsourcing, integration of pharmacogenomics, and strategies for repurposing drugs.

In the coming years, the drug discovery informatics market is set to undergo significant growth, expected to reach $6.98 billion in 2029 with a CAGR of 14.3%. This anticipated growth during the forecast period can be associated with the growth in precision medicine, the prediction of drug-drug interactions, the analysis of patient-derived data, the development of biosimilars, and an increased number of drug candidates. The forecast period is likely to witness certain trends including the integration of AI and machine learning, the use of digital twins in drug development, various collaboration platforms, the use of blockchain for data protection, advancements in imaging technologies, and the adoption of cloud-based informatics platforms.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8960

What Are the Different Drug Discovery Informatics Market Segments?
The drug discovery informatics market covered in this report is segmented -

1) By Service: In-House, Outsourced
2) By Modality: Cloud-Based Systems, In-Campus
3) By Application: Data Sequencing, Molecular Docking, Identification And Validation, Target Data Analysis
4) By End-User: Pharmaceutical Companies, Contract Research Organizations, Bio-Technology Companies

Subsegments:
1) By In-House: Data Management, Computational Chemistry, Bioinformatics, Cheminformatics, Predictive Modeling, Other In-House Services
2) By Outsourced: Contract Research Organizations (CROs), Specialized Informatics Providers, Data Analysis And Management Services, Other Outsourced Services

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8960&type=smp

What Are the Primary Drivers Shaping the Drug Discovery Informatics Market?
The escalation in several chronic diseases is anticipated to lead to an upswing in the growth of the drug discovery informatics market in future. Chronic diseases are generally defined as conditions that last for a year or more, requiring continual medical attention, interfering with daily activities, or both. The tools provided by drug discovery informatics aid in chronic disease care advancement by enabling researchers to explore intricate and fleeting molecular variations, which form the foundation of disease development and drug response, subsequently resulting in multi-dimensional models of the entire hierarchical system in healthy, diseased and treated states. For example, a report from the World Health Organization - a Switzerland-based United Nations body committed to global public health, projected that in 2022, non-transmittable diseases (NCDs) would cause the death of 41 million people, constituting 74% all global deaths. Every year, NCDs claim the lives of 17 million people under the age of 70, with a staggering 86% of these premature deaths occurring in low-to-middle income countries. Cardiovascular diseases claim the most lives annually (17.9 million), with subsequent highest fatalities caused by cancer (9.3 million), chronic respiratory conditions (4.1 million), and diabetes (2 million, inclusive of kidney disease fatalities due to diabetes). Hence, the escalating incidences of various chronic diseases are fueling the growth of the drug discovery informatics market.

Which Companies Are Leading in the Drug Discovery Informatics Market?
Major companies operating in the drug discovery informatics market include accenture* Plc., Certara Inc., Charles River Laboratories Inc., Infosys Ltd., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products Inc., Jubilant Biosys Ltd., Selvita S.A., PerkinElmer Inc., International Business Machines Corporation, Boehringer Ingelheim International GmbH, Oracle Corporation, Thermo Fisher Scientific Inc., Albany Molecular Research Inc., ChemAxon Ltd., Amazon Web Services Inc., Schrödinger LLC., Core Informatics LLC, Informatics Matters Ltd., Tata Consultancy Services Limited, Novo Informatics Pvt. Ltd., IO Informatics Inc., GVK Biosciences Private Limited, Dassault Systèmes SE, Recursion Pharmaceuticals Inc., Cyclica Inc., Valence Discovery Inc., Valo Health Inc., Cognizant Technology Solutions Corporation, Wipro Limited, Mindtree Limited, Persistent Systems Limited, Mphasis Limited

What Are the Major Trends Shaping the Drug Discovery Informatics Market?
The rise of technological innovations is a prominent trend observed in the drug discovery informatics sector. The foremost market participants are focusing on the development of technologically advanced solutions to maintain and enhance their market standing. For example, in March 2023, Illumina Inc., a biotechnology firm based in the US, introduced Connected Insights. This new cloud-based software facilitates tertiary analysis for clinical next-generation sequencing (NGS) data. The software is designed to accelerate interpretation and reporting from various assay types, permitting labs to boost the usage of NGS and decrease clinical reporting time through the integration of third-party knowledge bases. Furthermore, it aims to support a wide array of applications, including whole-genome sequencing (WGS) for rare diseases in the future. Illumina Connected Software is a comprehensive software ecosystem that standardizes analytic tools and consolidates data throughout the genomics workflow. By integrating with Illumina sequencers and providing access to the DRAGEN secondary analysis, the Illumina Connected Software creates an efficient, accurate, flexible analysis setting prepared to adapt to each customer's workflow.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/drug-discovery-informatics-global-market-report

What Are the Top Revenue-Generating Geographies in the Drug Discovery Informatics Market?
North America was the largest region in the drug discover informatics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug discovery informatics market during the forecast period. The regions covered in the drug discovery informatics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Drug Discovery Informatics Market?
2. What is the CAGR expected in the Drug Discovery Informatics Market?
3. What Are the Key Innovations Transforming the Drug Discovery Informatics Industry?
4. Which Region Is Leading the Drug Discovery Informatics Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.